Total Synthesis of Kibdelomycin
1Department of Chemistry, Scripps Research, 10550N. Torrey Pines Road, La Jolla, CA 92122, USA.
Angewandte Chemie (International Ed. in English)
|June 15, 2022
Summary
A modular synthesis of the antibiotic kibdelomycin was developed for structure-activity relationship studies. This research clarifies its structure and shows truncated versions lose antibacterial activity.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Antibiotic Research
Background:
- Kibdelomycin is an antibiotic with a complex structure.
- Amycolamicin is a related natural product with a similar structure.
- The precise structure and activity relationship of kibdelomycin remain incompletely understood.
Purpose of the Study:
- To develop a modular total synthesis of kibdelomycin.
- To enable structure-activity relationship (SAR) studies of kibdelomycin and related compounds.
- To clarify the structural assignment of kibdelomycin and its relationship to amycolamicin.
Main Methods:
- Modular total synthesis approach utilizing simple building blocks.
- Structural analysis to confirm assignment and compare with amycolamicin.
- Antibacterial assays to evaluate the activity of synthesized compounds and analogs.
Main Results:
- A modular synthetic route to kibdelomycin was successfully established.
- The synthesis provided insights into the structural assignment and relationship to amycolamicin.
- Both C-22 epimers of kibdelomycin exhibited similar antibacterial activity.
- Structurally truncated analogs of kibdelomycin demonstrated a loss of activity.
Conclusions:
- The developed modular synthesis facilitates SAR studies for kibdelomycin antibiotics.
- The study provides clarity on kibdelomycin's structure and its relation to amycolamicin.
- Antibacterial activity is dependent on the intact structure, particularly the N-glycosidic linkage at C-22.
More Related Videos
09:10Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
2.4K
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
18.6K
